Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Molecular Analysis of Virulence Gene ABA392 of P.multocida. Edition No. 1

VDM Publishing House, Aug 2009, Pages: 188


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

P.multocida serotype B is a worldwide potential pathogen causing haemorrhagic septicaemia (HS)cattle and buffalo. The pathogenesis of it is poorly understood. Thus, there is a need to identify the potential pathogenic properties of P. multocida.There is still no system that will definitively classify HS isolates. The whole idea of this study was to use the constructed recombinant clone to characterise the HS isolates via its unique sequences capability. The initial success in cloning, expression, hybridisation and sequencing of the virulence gene of recombinant clone ABA392 from P. multocida serotype B lend further support to the hypothesis postulated by Carter and Chengappa (1980) for the elucidation of the possible role of hyaluronidase enzyme as a virulence factor related to pathogenesis of haemorrhagic septicaemia. The fragment size of ABA392 was determined to be 921 nt and no homology found in the Genbank database. Much work remains for detailed studies of this novel gene. Various experts like biochemist, immunologist, clinician, veterinarian and farmers need to combine effort to achieve target in combating this disease.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds